BioSpace News Archive

Vanda Pharmaceuticals Inc. announced it will release results for the first quarter 2020 on Wednesday, May 6, 2020, after the market closes.

Penumbra, Inc. announced that its management team is scheduled to present at the Bank of America Merrill Lynch 2020 Health Care Conference on Wednesday, May 13, 2020.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2020 financial results.

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal second quarter ended March 28, 2020.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced its first quarter 2020 financial results and business highlights.

Clovis Oncology, Inc. announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the Bank of America Health Care Conference 2020 on Tuesday, May 12, 2020 at 10:20 a.m. Eastern time.

The employee analytics, engagement, monitoring and testing solution is designed to protect workers and foster confidence as employers lay out plans for workforce re-entry.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three months ended March 31, 2020 after the market closes on Wedn

AJOVY™ is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive treatment of migraine in adults

DiscernDx, today announced the expansion of the company’s precision medicine solutions with the acquisition of Luminist Labs, a privately-held novel diagnostic platform company for the early detection and diagnosis of liver disease.